ABL Diagnostics to acquire Texcell assets via French court ruling

July 23, 2026 3:22 AM EDT Send to a Friend
ABL Diagnostics (Euronext Paris: ABLD), a molecular diagnostics and healthcare software company based in Woippy, France, has been selected by ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login